Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.

about

Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

P2860

Q40060735-D1C954D3-082C-46E4-8E41-2188C53AEA0B Q57168537-077BBEA6-ACCB-4DF1-90FC-7B00F92F0980

P2860

Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.

Item

http://www.wikidata.org/entity/Q38859607

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pre- and post-diagnostic beta- ...... from a population-based study.

@en

type

Item

label

Pre- and post-diagnostic beta- ...... from a population-based study.

@en

prefLabel

Pre- and post-diagnostic beta- ...... from a population-based study.

@en

P1476

Pre- and post-diagnostic beta- ...... from a population-based study.

@en

P2093

Janick Weberpals

http://www.w3.org/2001/XMLSchema#string

Josephina G Kuiper

http://www.w3.org/2001/XMLSchema#string

Pauline A J Vissers

http://www.w3.org/2001/XMLSchema#string

P2860

Marginal structural models and causal inference in epidemiology

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage.

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.

Molecular pathways: beta-adrenergic signaling in cancer

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

P304

62-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30717

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28370155

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.

about

P2860

P2860

Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921